Association of hematological malignancies with clinical and financial outcomes following transcatheter aortic valve replacement

By afschroeder • August 7, 2025

Liu Z, Aguayo E, Porter G, Ali K, Zinoviev R, Benharash P. Association of hematological malignancies with clinical and financial outcomes following transcatheter aortic valve replacement. Clinics (Sao Paulo). 2025 Aug 5;80:100741. doi: 10.1016/j.clinsp.2025.100741. Epub ahead of print. PMID: 40769028.

Tags: Cardiology/Epi, Hematological malignancies, Nationwide Readmissions Database, Outcome, Publications, transcatheter aortic valve replacement

Metabolomics-Based Investigation of PFOS-Induced Molecular Perturbations Across Multiple Rat Organs

Yen TH, Lee SH, Liang HJ, Huang ZX, Chen CT, Li C, Lin CY. Metabolomics-Based Investigation of PFOS-Induced Molecular Perturbations Across Multiple Rat Organs. Environ[...]

Trimethylamine N-oxide and related metabolites may regulate DNA methylation and trigger cardiovascular disease

Ma J, Lai CQ, Li XS, Wang M, Wang Z, Yao J, Guo X, Taylor KD, Lee S, Tracy RP, Peter D, Liu Y, Rotter[...]

Transcatheter Pulmonary Valve Implantation With the Alterra Adaptive Prestent and SAPIEN 3 Transcatheter Heart Valve: 3-Year Pooled Outcomes of the ALTERRA Trials

Torres AJ, Dimas VV, Shahanavaz S, Balzer D, Morgan G, Lim DS, Armstrong AK, Berman D, Babaliaros V, Kim D, Gillespie MJ, Sommer R, Aboulhosn[...]